<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Biochem</journal-id><journal-title-group><journal-title>BMC Biochemistry</journal-title></journal-title-group><issn pub-type="epub">1471-2091</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3060122</article-id><article-id pub-id-type="publisher-id">1471-2091-12-7</article-id><article-id pub-id-type="pmid">21303506</article-id><article-id pub-id-type="doi">10.1186/1471-2091-12-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Stakkestad</surname><given-names>&#x000d8;ystein</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>oysteis@hotmail.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Larsen</surname><given-names>Anja CV</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>a.c.v.larsen@ernstud.uio.no</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Kvissel</surname><given-names>Anne-Katrine</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>a.k.kvissel@basalmed.uio.no</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Eikvar</surname><given-names>Sissel</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>sissel.eikvar@medisin.uio.no</email></contrib><contrib contrib-type="author" id="A5"><name><surname>&#x000d8;rstavik</surname><given-names>Sigurd</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>sigurdorstavik@hotmail.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A6"><name><surname>Sk&#x000e5;lhegg</surname><given-names>Bj&#x000f8;rn S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>b.s.skalhegg@medisin.uio.no</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, P.O. Box 1046 Blindern, N- 0316 OSLO, Norway</aff><aff id="I2"><label>2</label>Department of Biochemistry, Institute for Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, P.O. Box 1112 Blindern, N- 0317 OSLO, Norway</aff><aff id="I3"><label>3</label>Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Ullernchausseen 70, N-0310 Oslo, Norway</aff><aff id="I4"><label>4</label>Department of Oncology, Ullev&#x000e5;l Hospital, Oslo University Hospital, Kirkeveien 166, P.O. Box 4950, Nydalen N-0424, OSLO, Norway</aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>8</day><month>2</month><year>2011</year></pub-date><volume>12</volume><fpage>7</fpage><lpage>7</lpage><history><date date-type="received"><day>29</day><month>9</month><year>2010</year></date><date date-type="accepted"><day>8</day><month>2</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2011 Stakkestad et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Stakkestad et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2091/12/7"/><abstract><sec><title>Background</title><p>Protein kinase A type I (PKAI) and PKAII are expressed in most of the eukaryotic cells examined. PKA is a major receptor for cAMP and specificity is achieved partly through tissue-dependent expression and subcellular localization of subunits with different biochemical properties. In addition posttranslational modifications help fine tune PKA activity, distribution and interaction in the cell. In spite of this the functional significance of two forms of PKA in one cell has not been fully determined. Here we have tested the ability of PKAI and PKAII formed by expression of the regulatory (R) subunits RI&#x003b1; or RII&#x003b1; in conjunction with C&#x003b1;1 or C&#x003b2;2 to activate a co-transfected luciferace reporter gene, controlled by the cyclic AMP responsive element-binding protein (CREB) <italic>in vivo</italic>.</p></sec><sec><title>Results</title><p>We show that PKAI when expressed at equal levels as PKAII was significantly (p &#x0003c; 0.01) more efficient in inducing Cre-luciferace activity at saturating concentrations of cAMP. This result was obtained regardless of catalytic subunit identity.</p></sec><sec><title>Conclusion</title><p>We suggest that differential effects of PKAI and PKAII in inducing Cre-luciferace activity depend on R and not C subunit identity.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Cyclic 3', 5'-adenosine monophosphate (cAMP) is a key intracellular signaling molecule, which main function is to activate the cAMP-dependent protein kinases (PKA) [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. PKA is a heterotetrameric holoenzyme composed of two regulatory (R) and two catalytic (C) subunits, which is enzymatically inactive in the absence of cAMP. When two molecules of cAMP bind to each of the R subunits [<xref ref-type="bibr" rid="B3">3</xref>], the C subunits are released and activated to phosphorylate serine and threonine residues on specific intracellular target proteins [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Several PKA substrates have been identified of which the synthetic peptide Kemptide [<xref ref-type="bibr" rid="B6">6</xref>] and the naturally occurring substrate cAMP responsive element binding protein (CREB) are of the best characterized [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. In primates, four genes encoding the R subunit and four genes encoding the C subunit, have been identified and designated RI&#x003b1;, RI&#x003b2;, RII&#x003b1;, RII&#x003b2; and C&#x003b1;, C&#x003b2;, C&#x003b3; and X-chromosome encoded protein kinase X (PrKX) [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Whereas no splice variants for RI&#x003b2; and RII&#x003b2; have been described, RI&#x003b1; is transcribed from at least two different promoters. The first exons of the RI&#x003b1; gene, exon 1a and 1b, give rise to alternatively spliced but identical proteins RI&#x003b1;1a and RI&#x003b1;1b [<xref ref-type="bibr" rid="B10">10</xref>]. RI&#x003b1; 1a and 1b mRNAs have been identified in most tissues and are differentially regulated by cAMP [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. In the case of RII, it has been shown that RII&#x003b1; in the human testis but no other tissues examined, is encoded with an alternative amino-terminal region [<xref ref-type="bibr" rid="B14">14</xref>]. No functional consequences of alternative splicing of RI and RII have been reported.</p><p>Several splice variants are transcribed from the C&#x003b1; and the C&#x003b2; genes (PRKCA and PRKCB) and include C&#x003b1;1, C&#x003b1;S, C&#x003b2;1, C&#x003b2;2, C&#x003b2;3 and C&#x003b2;4, in addition to an unknown number of abc forms of the C&#x003b2;3 and C&#x003b2;4 variants [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. The major differences between the various C subunits are introduced through alternative use of exon 1 in the PRKCB and PRKCA genes, respectively [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. In the case of C&#x003b1;1 exon 1-1 encodes an N-terminal stretch of 14 amino acids that have three sites that undergo co- and posttranslational modifications. At the very N-terminus a Gly is located that undergoes myristoylation <italic>in vivo </italic>[<xref ref-type="bibr" rid="B23">23</xref>]. C-terminal to the Gly an Asn is located that is partly deamidated <italic>in vivo </italic>leading to C&#x003b1;1-Asp2 and C&#x003b1;1-iso(&#x003b2;)Asp2 [<xref ref-type="bibr" rid="B24">24</xref>]. The third modification is PKA-autophosphorylation at Ser10 [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. In the case of C&#x003b2;2, exon 1-2 encodes an N-terminal stretch of 62 amino acids that does not harbor sites for any of the modifications identified in C&#x003b1;1. Instead, the C&#x003b2;2 N-terminus contains a stretch of hydrophobic amino acids that form an amphiphatic &#x003b1;-helix displayed as a hydrophobic surface [<xref ref-type="bibr" rid="B20">20</xref>]. C&#x003b1;1 and C&#x003b2;1 are more than 90% identical at the amino acid level and are ubiquitously expressed. C&#x003b1;S has only been identified in sperm cells [<xref ref-type="bibr" rid="B28">28</xref>], C&#x003b2;2 is predominantly expressed in lymphoid cells [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>], and C&#x003b2;3 and C&#x003b2;4 and their abc variants are mainly expressed in neuronal tissues [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>].</p><p>It is assumed that any known C subunit may associate with RI and RII to form PKAI and PKAII, respectively [<xref ref-type="bibr" rid="B9">9</xref>]. This has raised the question of the biological significance of PKAI and II holoenzymes containing various C isoforms within the same cell. Whereas no reports have been published on the functional consequences of holoenzymes formed with various C subunits, it has been demonstrated that several cell types expressing RI&#x003b1; are highly proliferative and may also be associated with malignancy [<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B34">34</xref>]. Using a genetic approach it has also been demonstrated that constitutive ablation of RI&#x003b1; but not RI&#x003b2; is prenatal lethal whereas ablation of the RII variants results in more discrete defects, affecting differentiation of adipose tissue and neural functions[<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B37">37</xref>]. The levels of RI and RII as well as tissue- and subcellular expression varies. They also show differential affinities for A-kinase anchoring proteins (AKAP). Furthermore, when determining the structure of the PKA holoenzymes it was found that RI and RII contact the substrate binding site of the C subunit either as a true PKA substrate (RII) or as a pseudosubstrate (RI) due to autophosphorylation of RII but not RI at Ser95 [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. Despite these differences an explanation for biological differences at the cellular level between RI and RII are not fully appreciated [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. However, it should be noted that RII autophosphorylation modulates AKAP-RII interaction in cardiac cells, leading to altered down-stream substrate phosphorylation and Ca<sup>2+ </sup>dynamics [<xref ref-type="bibr" rid="B42">42</xref>].</p><p>To investigate biological differences between RI and RII and to demonstrate if such differences are dependent on C subunit identity we formed PKAI and PKAII by co-transfecting 293T cells with either RI&#x003b1; or RII&#x003b1; together with C&#x003b1;1 and C&#x003b2;2, respectively. This demonstrated that PKAI was superior to PKAII in activating a cAMP responsive element regardless of whether the holoenzyme contained C&#x003b1;1 or C&#x003b2;2. Our results contribute to understand the functional significance of two PKA holoenzymes but not various C subunits expressed in the same cell.</p></sec><sec><title>Results</title><p>To test for differential roles of PKAI and PKAII expressed in one cell we tested if markedly different C subunits released from RI and RII are equally effective in regulating <italic>in vivo </italic>substrate phosphorylation. We chose the cell line 293T as a model system since they express RI&#x003b1; and RII&#x003b1; associated with C&#x003b1;1 (Figure <xref ref-type="fig" rid="F1">1A</xref>, left panel), and not RI&#x003b2; and RII&#x003b2; (Figure <xref ref-type="fig" rid="F1">1A</xref>, right panel). In these cells PKAI and PKAII are distinctly located to the cytosol and Golgi-centrosomal area, respectively as demonstrated by immunostaining using anti-RI&#x003b1; (red) or anti-RII&#x003b1; (green) (Figure <xref ref-type="fig" rid="F1">1B</xref>). Co-immunostaining with anti-C demonstrated that C&#x003b1;1 localization corresponded to R subunit localization. We also observed a weak nuclear staining of the C subunit in the absence of cAMP (Figure <xref ref-type="fig" rid="F1">1C</xref>), whereas in the presence of the cAMP analogue, 8-CPT-cAMP (340 &#x000b5;M) an increase in nuclear staining was observed (Figure <xref ref-type="fig" rid="F1">1C</xref>). We concluded that the 293T cells represented a suitable model system to study isoform differences between PKAI and PKAII formed with different C subunits.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>PKAI (RI&#x003b1;C&#x003b1;1) and PKAII (RII&#x003b1;C&#x003b1;1) are expressed in 293T cells</bold>. <bold>(A) </bold>Cell extracts of 293T cells (40 &#x003bc;g protein/lane) were analyzed by immunoblotting using a pan-anti-C antibody (upper left panel) and anti-RI&#x003b1; and anti-RII&#x003b1; (lower left panels). The levels and identities of 293T cell C and R subunit expression were compared to human peripheral blood lymphocytes (hPBL) revealing expression of C&#x003b1;1, RI&#x003b1; and RII&#x003b1;. No detectable levels of RI&#x003b2; and RII&#x003b2; were identified when compared to extracts of human temporal cortex (hTempCortex, right panels). (<bold>B</bold>) Immunofluorescence analysis of PKA RI and RII in 293T cells. RI&#x003b1; (Anti-RI, red) is expressed diffusely in the cytosol and RII&#x003b1; (Anti-RII, green) is expressed in the Golgi-centrosomal area of 293T cells. (<bold>C</bold>) Immunofluorescence analysis of PKA C subunits in 293T treated without (-) or with (+) 340 &#x003bc;M 8-CPT-cAMP.</p></caption><graphic xlink:href="1471-2091-12-7-1"/></fig><p>To obtain 293T cells dominated by either PKAI or PKAII expression, we formed holoenzymes by transient transfection of plasmids over-expressing either RI&#x003b1; or RII&#x003b1; (pDeRI&#x003b1; or pExRII&#x003b1;) in combination with either C&#x003b1;1 or C&#x003b2;2 (pDeC&#x003b1;1 or pDeC&#x003b2;2). For some experiments the cells were also transfected with a vector expressing Luciferace controlled by a cAMP responsive element. C subunit activity was tested <italic>in vitro </italic>using Kemptide as a substrate [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]; and <italic>in vivo </italic>using the Cre-Luciferase reporter system [<xref ref-type="bibr" rid="B45">45</xref>]. This revealed a dose-dependent increase in PKA-specific catalytic activity against Kemptide for both pDeC&#x003b1;1 and pDeC&#x003b2;2 with a maximum at 5600 ng DNA (Figure <xref ref-type="fig" rid="F2">2A</xref>). The luciferase response was bell shaped and reached a maximum for pDeC&#x003b1;1 and pDeC&#x003b2;2 at 1400 and 2800 ng DNA, respectively (Figure <xref ref-type="fig" rid="F2">2B</xref>). Next, we titrated the plasmids expressing RI and RII by transfecting 0-1280 ng of the plasmids pDeRI&#x003b1; and pExRII&#x003b1;, respectively (Figure <xref ref-type="fig" rid="F2">2C, D</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Activity of PKA R and C subunits expressed in 293T cells</bold>. <bold>(A and B) </bold>293T cells were left untransfected, transfected with empty vector (vector) or with increasing amounts (0 - 5600 ng) of either pDeC&#x003b1;1 (C&#x003b1;1, &#x02014;) or pDeC&#x003b2;2 (C&#x003b2;2, ------). After 24 hours cells were harvested, homogenized and all cell extracts adjusted to 1 mg total protein/mL. PKA activity was determined as catalytic activity against Kemptide in the presence of 7.14 &#x003bc;M cAMP (<bold>A</bold>) and Luciferase activity at 560 nm (<bold>B)</bold>. Data points represent enzyme activity and relative luciferase activity, respectively, +/- SD, n = 3. (<bold>C and D</bold>) 293T cells were left untransfected, transfected with empty vector (vector) or with increasing amounts (10 - 1280 ng) of either pDeRI&#x003b1; or pExRII&#x003b1;. Levels of R subunit expression were monitored as [<sup>3</sup>H]-cAMP-binding and R subunit immunoreactivity against RI&#x003b1; (<bold>C</bold>, clone 4D7, 1: 300 dilution) or anti-RII&#x003b1; (<bold>D</bold>, 1 : 400 dilution) after SDS-PAGE separation of 25 &#x003bc;g total protein per lane in 12.5 <italic>% </italic>gels. R subunit activities are given as cpm +/- SD (n = 3). The apparent molecular weight of protein recognized is indicated by arrows and protein identity RI&#x003b1; (49 kDa) and RII&#x003b1; (52 kDa), given by arrows to the left. One immunoblot out of three independent experiments is shown.</p></caption><graphic xlink:href="1471-2091-12-7-2"/></fig><p>Twenty four hours after transfection cells were lysed and R subunit levels were measured by immunoblotting and [<sup>3</sup>H]-cAMP-binding. This revealed an increase in a 49 kDa immunoreactive band as well as increased [<sup>3</sup>H]-cAMP-binding that coincided with the amount of plasmid transfected (pDeRI&#x003b1;, Figure <xref ref-type="fig" rid="F2">2C</xref>). The same was the case when transfecting pExRII&#x003b1; (Figure <xref ref-type="fig" rid="F2">2D</xref>). Together this demonstrated a dose-dependent expression of both RI&#x003b1; and RII&#x003b1;.</p><p>Based on these transfections and earlier experiments (results not shown), we next formed PKA holoenzymes by R and C co-transfections. We aimed at transfecting R plasmids to levels where C activity in the absence of cAMP were at basal levels, implying levels of R able to associate with all C subunits. 293T cells were co-transfected with a fixed amount of either pDeC&#x003b1;1 (300 ng) or pDeC&#x003b2;2 (1400 ng) together with increasing amounts of pDeRI&#x003b1; (0-1280 ng, Figure <xref ref-type="fig" rid="F3">3A, B</xref>) and pExRII&#x003b1; (0-1280 ng, Figure <xref ref-type="fig" rid="F3">3C, D</xref>), respectively. Cell extracts were adjusted to 1 mg total protein/mL and total C subunit activity measured in the presence and absence of 7.14 &#x003bc;M cAMP. This demonstrated that C&#x003b1;1-specific kinase activity was inhibited down to basal levels in the absence of cAMP at 640 ng pDeRI&#x003b1; (Figure <xref ref-type="fig" rid="F3">3A</xref>), which was equal to 28 &#x000b1; 1.4 pmol RI&#x003b1;/mg total protein (Table <xref ref-type="table" rid="T1">1</xref>). In the case of C&#x003b2;2-specific activity it was down to basal levels in the absence of cAMP at 80 ng pDeRI&#x003b1; (Figure <xref ref-type="fig" rid="F3">3B</xref>) which was equal to 11.8 &#x000b1; 2.7 pmol RI&#x003b1;/mg total protein (Table <xref ref-type="table" rid="T1">1</xref>). For RII&#x003b1;, 320 ng pExRII&#x003b1; was required for optimal C&#x003b1;1 inhibition (Figure <xref ref-type="fig" rid="F3">3C</xref>), which was equal to 16.2 &#x000b1; 0.5 pmol RII&#x003b1;/mg total protein (Table <xref ref-type="table" rid="T1">1</xref>). Finally, 80 ng pExRII&#x003b1; was required to inhibit C&#x003b2;2 activity to basal levels (Figure <xref ref-type="fig" rid="F3">3D</xref>) which was equal to 9.6 &#x000b1; 2 pmol RII&#x003b1;/mg total protein. In order to compare <italic>in vitro </italic>and <italic>in vivo </italic>PKA activity, protein extracts were analyzed against Kemptide phosphorylation and luciferace activity after transfection with Cage-Cre-Luciferase (700 ng) together with either 300 ng pDeC&#x003b1;1 or 1400 ng pDeC&#x003b2;2 and increasing amounts of pDeRI&#x003b1; and pExRII&#x003b1; (160-1280 ng DNA, Figure <xref ref-type="fig" rid="F4">4A-D</xref>). In these experiments psv-&#x003b2;-Galactosidase (1000 ng) was used for normalization (see Methods). This showed that luciferase activity induced by C&#x003b1;1 and C&#x003b2;2 was completely inhibited by both RI&#x003b1; and RII&#x003b1; at doses above or equal to 640 ng plasmid DNA.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Expressed RI&#x003b1; and RII&#x003b1; inhibit expressed C&#x003b1;1 and C&#x003b2;2 catalytic activity in a dose-dependent manner</bold>. 293T cells were co-transfected with increasing amounts (0-1280 ng) of either pDeRI&#x003b1; (<bold>A and B</bold>) or pExRII&#x003b1; (<bold>C and D</bold>) with a fixed amount of pDeC&#x003b1;1 (300 ng, <bold>A and C</bold>) or pDeC&#x003b2;2 (1400 ng, <bold>B and D</bold>). Cells were harvested after 24 hours, cell extracts adjusted to 1 mg total protein/mL and assayed for PKA-specific phosphotransferase activity in the presence (+ cAMP) and absence (- cAMP) of 7.14 &#x003bc;M cAMP. Data points represent pmol ATP transferred/min/mg protein) +/- SD (n = 2-6).</p></caption><graphic xlink:href="1471-2091-12-7-3"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Concentrations of RI and RII required for maximal inhibition of transfected C subunit</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Subunits</th><th align="left">C&#x003b1;1 (300 ng DNA)</th><th align="left">C&#x003b2;2 (1400 ng DNA)</th></tr></thead><tbody><tr><td align="left">RI&#x003b1;</td><td align="left">28 &#x000b1; 1.4 *</td><td align="left">11.8 &#x000b1; 2.7</td></tr><tr><td align="left">RII&#x003b1;</td><td align="left">16.2 &#x000b1; 0.5</td><td align="left">9.6 &#x000b1; 2</td></tr></tbody></table><table-wrap-foot><p><bold>* </bold>Concentration of R subunit (pmol/mg protein) required for 100% inhibition of C&#x003b1;1 and C&#x003b2;2 activity.</p></table-wrap-foot></table-wrap><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Expressed RI&#x003b1; and RII&#x003b1; inhibit C&#x003b1;1- and C&#x003b2;2-dependent CREB phosphorylation in a dose-dependent manner</bold>. 293T cells were co-transfected with increasing amounts (0-1280 ng) of either pDeRI&#x003b1; (<bold>A and B</bold>) or pExRII&#x003b1; (<bold>C and D</bold>) and a fixed amount of pDeC&#x003b1;1 (300 ng, <bold>A and C</bold>) or pDeC&#x003b2;2 (1400 ng, <bold>B and D</bold>). Cells were harvested after 24 hours and cell extracts adjusted to 1 mg total protein/mL and assayed at 560 nm for PKA-specific phosphorylation of CREB measured as CRE-activity. Data points represent relative luciferase activity +/- SD (n = 2-6).</p></caption><graphic xlink:href="1471-2091-12-7-4"/></fig><p>The experiments in Figures <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref> depict that C&#x003b2;2 activity is fully inhibited at lower amounts of R than C&#x003b1;1 is. This may imply that C&#x003b1;1 is enzymatically more active than C&#x003b2;2 or simply that C&#x003b2;2 is more unstable than C&#x003b1;1 in the absence of R. A previous report shows that the C subunit in its free active form is more rapidly degraded than C complexed with the R subunit dimer [<xref ref-type="bibr" rid="B46">46</xref>]. To test if C&#x003b1;1 and C&#x003b2;2 display differential stability, identical amounts of C&#x003b1;1 and C&#x003b2;2 plasmids were transfected alone or with 1280 ng of pDeRI&#x003b1;. This confirmed (Figure <xref ref-type="fig" rid="F5">5</xref> bars 2 and 3) that in the absence of RI&#x003b1; total C&#x003b2;2 activity is significantly (* p&#x0003c; 0.05) lower compared to C&#x003b1;1. This was not the case when RI&#x003b1; was co-transfected with the two C subunits. In this case both C&#x003b1;1 and C&#x003b2;2 activities were increased, however, to comparable levels after stimulation with cAMP (bars 5 and 7, ns). This demonstrated that RI&#x003b1; has a stabilizing effect on both C subunits. However the effect was more pronounced for C&#x003b2;2 than C&#x003b1;1 indicating that C&#x003b2;2 is more unstable than C&#x003b1;1 in the absence of R.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>C&#x003b1;1 and C&#x003b2;2 proteins are stabilized by RI&#x003b1;</bold>. 293T cells were untransfected (M) or transfected with fixed amounts of either pDeC&#x003b1;1 (300 ng) or pDeC&#x003b2;2 (1400 ng) in conjunction with 1280 ng (bars 4 to 7) or without (bars 1-3) pDeRI&#x003b1; for 24 h. Cell extracts were adjusted to 1 mg total protein/mL and assayed for PKA-specific phosphotransferase activity in the absence (- cAMP) and presence (+ cAMP) of 320 nM cAMP. Data points represent pmol ATP transferred/min/mg protein) +/- SD (n = 3). The relative activities of C&#x003b2;2 and C&#x003b1;1 in the absence of RI&#x003b1; were significantly different (* p &#x0003c; 0.02, bars 2 and 3). When C&#x003b1;1 and C&#x003b2;2 were co-transfected with RI&#x003b1; the relative activities were indistinguishable (bars 5 and 7, ns).</p></caption><graphic xlink:href="1471-2091-12-7-5"/></fig><p>The results from Figures <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref> demonstrated that we had obtained cell systems dominated by either PKAI or PKAII. Hence, the effects of PKAI and PKAII on <italic>in vitro </italic>(Kemptide) and <italic>in vivo </italic>(CREB) phosphorylation could be tested. For these experiments we used amounts of RI&#x003b1; and RII&#x003b1; required for complete inhibition of C&#x003b1;1 and C&#x003b2;2 respectively.</p><p>After 24 hours cell extracts were diluted to 1 mg total protein/mL and analyzed for cAMP dose-dependent induction of PKA kinase activity against Kemptide (Figure <xref ref-type="fig" rid="F6">6A, C</xref>). Both RI&#x003b1; and RII&#x003b1; were able to inhibit C&#x003b1;1 and C&#x003b2;2 kinase activity completely in the absence of cAMP. When increasing the concentrations of cAMP from 5 to 5000 nM, kinase activity was peaking, in the case of C&#x003b1;1 at 100 nM cAMP when co-expressed with RI&#x003b1; and between 500 and 5000 nM when co-expressed with RII&#x003b1;. In the case of C&#x003b2;2, maximum activity was achieved at concentrations between 500 and 5000 nM cAMP when co-expressed with both RI&#x003b1; and RII&#x003b1;. We further analyzed C subunit activity <italic>in vivo </italic>by measuring luciferace activity. Activity was measured after stimulation of the transfected cells with increasing concentrations of 8-CPT-cAMP (0 - 320 &#x003bc;M) for 1 hour prior to harvesting. We observed that activity associated with C&#x003b1;1 and C&#x003b2;2 released from both RI&#x003b1; and RII&#x003b1; increased in a dose-dependent manner, reaching maximum between 160 and 320 &#x003bc;M 8-CPT-cAMP (Figure <xref ref-type="fig" rid="F6">6B, D</xref>). However, a more than two fold higher activity was observed against CREB when C&#x003b1;1 and C&#x003b2;2 were released from RI&#x003b1; than from RII&#x003b1;. Together these results indicated that the ability of C to phosphorylate nuclear substrates <italic>in vivo </italic>at saturating concentrations of cAMP when associated with PKAII was lower than when associated with PKAI. This was apparent despite that total C subunit activity <italic>in vitro </italic>was comparable and protein concentrations were equal (Figure <xref ref-type="fig" rid="F6">6A</xref> to <xref ref-type="fig" rid="F6">6D</xref>). Since these results were seen regardless of C subunit isoform we suspected that the differences observed were associated with R subunit identity. To quantify the different efficacy of PKAI and PKAII to phosphorylate CREB <italic>in vivo</italic>, we therefore co-transfected pDeRI&#x003b1; (640 ng) and pExRII&#x003b1; (320 ng) with C&#x003b1;1 (300 ng pDeC&#x003b1;1) and monitored [<sup>3</sup>H]-cAMP binding. This showed equal activities (Figure <xref ref-type="fig" rid="F7">7A</xref>) and hence comparable levels (Table <xref ref-type="table" rid="T2">2</xref>) revealed as 22 &#x000b1; 1.5 and 23 &#x000b1; 1.5 pmol per mg total protein of RI&#x003b1; and RII&#x003b1;, respectively. We next determined C subunit activity <italic>in vitro </italic>after transfecting cells as described in Figure <xref ref-type="fig" rid="F7">7A</xref>, and in the absence (0 nM) and presence of two concentrations of cAMP (5 and 5000 nM). This revealed basal activity in the absence, and low level activity in the presence of 5 nM cAMP whereas 5000 nM cAMP resulted in comparable high levels of total C subunit activity released from both PKAI and PKAII (Figure <xref ref-type="fig" rid="F7">7B</xref>). The C activities were equal to 25 &#x000b1; 1.4 and 24.2 &#x000b1; 2.9 pmol C&#x003b1;1 per mg total protein for PKAI and PKAII, respectively (Table <xref ref-type="table" rid="T2">2</xref>). This concluded that PKAI and PKAII were expressed at comparable levels under the present conditions. The latter was substantiated by a calculated R to C ratio close to 1 for both RI&#x003b1; versus C&#x003b1;1 (ratio 0.88) and RII&#x003b1; versus C&#x003b1;1 (ratio 0.96, Table <xref ref-type="table" rid="T2">2</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Both PKAI and PKAII are activated to phosphorylate Kemptide but not CREB at saturating conditions of cAMP</bold>. 293T cells were co-transfected with a fixed amount (1280 ng) of either pExRII&#x003b1; or pDeRI&#x003b1; together with pDeC&#x003b1;1 (300 ng) (<bold>A and B</bold>) or pDeC&#x003b2;2 (1400 ng) (<bold>C and D</bold>) for 24 hours. Cell extracts were adjusted to 1 mg total protein/mL and assayed for enzyme activity (cpm,) in the presence of increasing concentrations of cAMP (0 - 5000 nM) (<bold>A and C</bold>). Identical cell extracts were assayed for relative luciferase activity (<bold>B and D</bold>). Data points represent relative enzyme activity and luciferase activity, +/- SD (n = 3-6).</p></caption><graphic xlink:href="1471-2091-12-7-6"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>PKAII is less efficient compared to PKAI in regulating CRE activity <italic>in vivo</italic></bold>. 293T cells were co-transfected with or without (empty vector, M), pDeC&#x003b1;1 (300 ng) together with either pExRII&#x003b1; (320 ng) or pDeRI&#x003b1; (640 ng) for 24 h (<bold>A- C</bold>). (<bold>A</bold>) R subunit-specific activity (pmol cAMP/mg protein) was monitored in the presence of 25 &#x003bc;M [<sup>3</sup>H]-cAMP and showed comparable levels of RI&#x003b1; and RII&#x003b1;. (<bold>B</bold>) Catalytic activity of C&#x003b1;1 was monitored in the absence (0) and presence of low (5 nM) and high (5000 nM) concentrations of cAMP. In the presence of 5000 nM cAMP levels of transfected C&#x003b1;1 released from RI&#x003b1; and RII&#x003b1; were equal. (<bold>C</bold>) The stability of RI&#x003b1; and RII&#x003b1; was monitored in the presence (+) and absence (-) of C&#x003b1;1 and the absence (0) and presence of incremental doses (1-320 &#x003bc;M) of 8-CPT-cAMP. R subunit stability was determined according to immunoreactive R subunits after separation of cell extracts (25 &#x003bc;g total protein) on SDS-PAGE (12.5 <italic>% </italic>gels) and anti-RI&#x003b1; (1 : 300 dilution, upper panel) and anti-RII&#x003b1; (1 : 400 dilution, lower panel). (<bold>D) </bold>293T cells were left untreated (0) or stimulated for 1 hour with 8-CPT-cAMP (320 &#x003bc;M) before harvesting. Cell extracts were adjusted to 1 mg total protein/mL and assayed for PKA-specific phosphorylation of CREB monitored as relative luciferase activity at 560 nm. Data points represent relative luciferase activity +/- SD (n = 2-6).</p></caption><graphic xlink:href="1471-2091-12-7-7"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Ratios of transfected R and C subunits</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">PKA subunits</th><th align="left">[R]*</th><th align="left">[C]</th><th align="left">R/C ratio</th></tr></thead><tbody><tr><td align="left">Holoenzyme</td><td/><td/><td/></tr><tr><td align="left">PKAI</td><td align="left">22 &#x000b1; 1.5</td><td align="left">25 &#x000b1; 1.4</td><td align="left">0.88</td></tr><tr><td align="left">PKAII</td><td align="left">23 &#x000b1; 1.5</td><td align="left">24 &#x000b1; 2.9</td><td align="left">0.96</td></tr></tbody></table><table-wrap-foot><p>* Concentration of R and C subunit (pmol/mg protein) were determined at saturating concentrations of cAMP and assuming two cAMP binding sites per R subunit and 600 pmol phosphate transferred by pure bovine C per min per mg [<xref ref-type="bibr" rid="B65">65</xref>].</p></table-wrap-foot></table-wrap><p>In lymphoid cells, it has been demonstrated that R subunits are more stable in the holoenzyme form compared to the free R subunit [<xref ref-type="bibr" rid="B47">47</xref>]. To test if the presence of C&#x003b1;1 alone and in conjunction with cAMP would influence R subunit levels we transfected 293T cells with either pDeRI&#x003b1; (640 ng) or pExRII&#x003b1; (320 ng) alone or in conjunction with pDeC&#x003b1;1 (300 ng). Transfected cells were treated without (0) or with incremental doses (1-320 &#x003bc;M) of 8-CPT-cAMP for four hours before harvesting. Equal amounts of cell extracts (50 &#x003bc;g total protein per lane) were analyzed for proteins immunoreactive to anti-RI&#x003b1; and anti-RII&#x003b1;, respectively. Figure <xref ref-type="fig" rid="F7">7C</xref> shows that 8-CPT-cAMP stimulation appeared not to influence R subunit levels and thus the cAMP sensitivity of the system.</p><p>Based on our observations (Figure <xref ref-type="fig" rid="F6">6B</xref> and <xref ref-type="fig" rid="F6">6D</xref>), we transfected cells as described in Figure <xref ref-type="fig" rid="F7">7B</xref> with equal amounts of PKAI and PKAII and monitored luciferace activity after stimulation with two concentrations of 8-CPT-cAMP (1 and 320 &#x003bc;M) for 1 hour before harvesting. As depicted in Figure <xref ref-type="fig" rid="F7">7D</xref> 320 &#x003bc;M 8-CPT-cAMP induced more than a 13-fold increase in luciferace activity when associated with RI&#x003b1; compared to untreated cells. When associated with RII&#x003b1; the induction was 3-fold. This difference was reflected in a relative induction of luciferace activity which was nearly twice as high for PKAI compared to PKAII (1.94 fold, p &#x0003c; 0.01).</p></sec><sec><title>Discussion</title><p>Despite that PKAI and PKAII are located to different areas when expressed in the same cell, it is believed that when dissociated by cAMP, the C subunits are all released to phosphorylate relevant substrates both in the cytosol and nucleus [<xref ref-type="bibr" rid="B48">48</xref>]. We formed PKAI and PKAII holoenzymes by co-transfecting 293T cells with RI&#x003b1; or RII&#x003b1; together with either C&#x003b1;1 or C&#x003b2;2.</p><p>We found that C subunits, irrespective of isoform, appeared more efficient in inducing Cre-luciferase when released from PKAI than PKAII.</p><p>To monitor total PKA activity <italic>in vitro </italic>and <italic>in vivo </italic>we applied cAMP and the cAMP analogue 8-CPT-cAMP. <italic>In vitro </italic>activation of PKA by cAMP was done to monitor if we had achieved comparable amounts of PKAI and PKAII in our experiments. For monitoring <italic>in vivo </italic>endogenous activity 8-CPT-cAMP was used because it has cell membrane permeable properties and is resistant to phosphodiesterase degradation [<xref ref-type="bibr" rid="B49">49</xref>]. The observation that cells transfected with PKAI induced higher levels of luciferace activity upon 8-CPT-cAMP stimulation than cells transfected with PKAII may have been due to relative affinities of the cAMP analogue. We consider this unlikely since 8-CPT-cAMP is a B-site selective cAMP analogue with higher affinity for RII than RI [<xref ref-type="bibr" rid="B49">49</xref>]. Further support for 8-CPT-cAMP as a competent activator of PKAII <italic>in vivo </italic>is found in that the concentration of 8-CPT-cAMP used is capable of displacing the C subunit from the RII subunit interacting with the centrosome <italic>in vivo </italic>in U2OS cells [<xref ref-type="bibr" rid="B50">50</xref>]. Taken together we conclude that 8-CPT-cAMP is fully capable to activate PKAII and does not selectively activate PKAI, implying that PKAII is less potent compared with PKAI in inducing Cre-luciferase activity.</p><p>An explanation for the biological significance of the phenomenon observed may rely on several factors. Despite that 25% of PKA is undissociated even in the presence of saturating concentrations of cAMP [<xref ref-type="bibr" rid="B51">51</xref>] it may not account for the differences we observed since this is observed for both PKAI and PKAII. However, it has been demonstrated that cAMP-dissociated RII and C reassociate much faster and to a much greater extent than RI and C. In fact it has been suggested that C does not really leave RII under physiological conditions due to a rapid reassociation [<xref ref-type="bibr" rid="B52">52</xref>]. Hence, incomplete dissociation of C subunit from RII even at saturating concentrations of cAMP could be a mechanism explaining the phenomena observed here. Moreover, the biological significance of differential effects of activating PKAI and PKAII independent of C subunit identity may be multiple. Recently a paper by Di and co-workers [<xref ref-type="bibr" rid="B53">53</xref>] demonstrated that PKAI and PKAII define distinct intracellular signaling compartments. They demonstrated that PKAI and PKAII activity were regulated by distinct, spatially restricted cAMP signals generated in response to specific G protein-coupled receptors and which were regulated by unique subsets of the cAMP degrading phosphodiesterases.</p><p>We observed that C&#x003b1;1 was more active than C&#x003b2;2 when expressed in non-holoenzyme form. This may suggest differential K<sub>d </sub>of C&#x003b1;1 and C&#x003b2;2 against RI and RII. This suggestion was supported in that the amount of R plasmid required for complete inhibition of C&#x003b1;1 and C&#x003b2;2, respectively, was higher for RI compared to RII regardless of C subunit identity (28 pmol RI&#x003b1;/mg protein and 15 pmol RII&#x003b1;/mg protein for C&#x003b1;1 versus ~12 pmol RI&#x003b1;/mg protein and ~10 pmol RII&#x003b1;/mg protein for C&#x003b2;2). However, we also observed that C&#x003b2;2, but not C&#x003b1;1 activity was stabilized when co-transfecting with the R subunit implying that the differences observed is due to protein instability of the C&#x003b2;2 subunit and not lower K<sub>d </sub>for the R subunit.</p><p>The latter is supported by the observation that R and C dissociation by cAMP <italic>in vivo </italic>promotes degradation of C subunits through posttranslational mechanisms which may involve proteasome action [<xref ref-type="bibr" rid="B54">54</xref>]. Furthermore, it has been shown that C&#x003b1;1 and C&#x003b2;1 have identical K<sub>d </sub>values for RI [<xref ref-type="bibr" rid="B55">55</xref>]. To what extent C&#x003b2;2 is more sensitive to proteasome degradation than C&#x003b1;1 is not known. It should however be noted that the marked differences between the C&#x003b1;1 and C&#x003b2;2 at the N-terminus has been implicated in C subunit stability. For C&#x003b1;1 it has been demonstrated that the &#x003b1;-helix and Trp 30 are vital moieties for C&#x003b1;1 stability. This correlates with the location of the N-terminal at the cleft interface where it orients the C-helix in the small lobe and the activation loop in the large lobe so that these subdomains are aligned in a way that allows for correct configuration of residues at the active site [<xref ref-type="bibr" rid="B56">56</xref>]. Moreover, we did not demonstrate a relative difference in potency of C&#x003b2;2 versus C&#x003b1;1 in inducing Cre-luciferase activity irrespective of association with RI&#x003b1; or RII&#x003b1;. The latter may suggest that C&#x003b1;1 and C&#x003b2;2 behave identically in regulating Cre-luciferase activities. Hence, we concluded that the differential effects of PKAI and PKAII on luciferase activity detected in the present work are associated with R subunit but not C subunit. The latter was unexpected since it has been speculated if the marked sequence differences at the N-terminus will influence PKA holoenzyme features as such as localization. The latter has previously been demonstrated in that the N-terminus of C&#x003b1;1 is implicated in subcellular anchoring to A-kinase interacting protein 1 (AKIP1) [<xref ref-type="bibr" rid="B57">57</xref>]. Furthermore, at the N-terminal end the myristoyl moiety, which binds to a hydrophobic pocket on the surface of the large lobe when C&#x003b1;1 subunit is in the holoenzyme form [<xref ref-type="bibr" rid="B58">58</xref>,<xref ref-type="bibr" rid="B59">59</xref>], is exposed to the surroundings upon binding to RII. This makes the holoenzyme more hydrophobic [<xref ref-type="bibr" rid="B60">60</xref>]. In addition, whereas the N-terminal Asn moiety, is involved in fine-tuning of the enzyme distribution within the cell <italic>in vivo </italic>[<xref ref-type="bibr" rid="B61">61</xref>], Ser10 phosphorylation is known to introduce electro statically mediated forces which may help C to remain soluble even when myristoylated [<xref ref-type="bibr" rid="B62">62</xref>-<xref ref-type="bibr" rid="B64">64</xref>]. Together this implies the N-terminal of C&#x003b1;1 to contribute to regulation and tuning of subcellular targeting. Despite lack of experimental evidence the N-terminal amphiphatic &#x003b1;-helix in C&#x003b2;2 has been proposed to function as a targeting domain for C&#x003b2;2 <italic>in vivo </italic>[<xref ref-type="bibr" rid="B20">20</xref>]. Despite the obvious differences between C&#x003b1;1 and C&#x003b2;2 we did not observe any experimental evidence on the C subunits contributing to understand the differential effects of PKAI and PKAII.</p><p>In perspective, the various reports referred to here [<xref ref-type="bibr" rid="B51">51</xref>-<xref ref-type="bibr" rid="B53">53</xref>] together with our observations demonstrate differential activities and regulation by PKAI and PKAII which may add to understand the biological significance of two PKA holoenzymes expressed in one cell.</p></sec><sec><title>Conclusions</title><p>This study is important because it points to how tissue-dependent expression of genes encoding subunits of PKA achieve specificity in the cAMP signaling pathway. Our work shows that transfected PKAI holoenzymes are more efficient than PKAII in phosphorylating CRE elements <italic>in vivo </italic>regardless of C subunit identity. Furthermore we show that C&#x003b2;2 appear more stable in the presence of R subunit than C&#x003b1;1.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Cell culture</title><p>293T HEK cells were maintained in RPMI medium 1640 (Sigma) containing 10% (v/v) Fetal Bovine Serum (Sigma), 2 mM L-Glutamine (Sigma) 1<italic>% </italic>Non-essential amino acids (Gibco), 1<italic>% </italic>Na-Pyruvat (Gibco) and 1% (v/v) Penicillin/Streptomycin (Sigma). The cells were subcultured three times weekly. Twenty hours before transfection 293T cells were grown in 6 well plates from a population of 0.7 &#x000d7; 10<sup>6 </sup>cells per well containing 1.5 mL RPMI medium without Penicillin/Streptomycin. Plates were kept at 37&#x000b0;C in a humidified atmosphere under 5<italic>% </italic>CO<sub>2</sub>.</p></sec><sec><title>Generation and expression of PKA vectors</title><p>pEF-DEST 51&#x02122;(Invitrogen) expression vectors encoding human regulatory and catalytic subunits RI&#x003b1;, C&#x003b1;1 and C&#x003b2;2 were created using Gateway LR Clonase Reaction<sup>&#x000ae; </sup>(Invitrogen) and transformed into Library<sup>&#x000ae; </sup>efficiency DH5&#x003b1;&#x02122;Competent cells (Invitrogen). Plasmid pBluescript containing RII&#x003b1; encoding fragment was digested with Eag I (New England Biolabs), ligated using T4 Ligase (Promega) in plasmid pExchange 6A (Promega) previously digested with Not I (Promega), and transformed into Ultramax<sup>&#x000ae; </sup>DH5&#x003b1;&#x02122;Competent cells (Invitrogen). Plasmids expressing catalytic subunits C&#x003b1;1 or C&#x003b2;2 or/and regulatory subunits RII&#x003b1; or RI&#x003b1; herby termed pDeC&#x003b1;1, pDeC&#x003b2;2, pDeRI&#x003b1;, and pExRII&#x003b1; where transfected using Lipofectamine 2000 (Invitrogen). In order to facilitate a reporter system, plasmids expressing Luciferase reporter gene and &#x003b2;-Galactosidase as a normalization control was co-transfected with R subunit and/or C subunit in constant amounts (0.7 &#x003bc;g Cage-Cre-Luciferase reporter vector and 1 &#x003bc;g Psv-&#x003b2;-Galactosidase vector) in all wells except wells kept as "mock" controls. A vector without insert was used to keep the amount of plasmid DNA transfected constant. Cells were stimulated with 8-CPT-cAMP for 1 or 4 hours (specified in the text) before being harvested 24 hours post transfection.</p></sec><sec><title>Immunoblot analysis</title><p>Immuno blotting was performed as previously described [<xref ref-type="bibr" rid="B15">15</xref>]. Membranes were incubated with mouse monoclonal anti-RII&#x003b2; (cat # 610625, BD Transduction laboratories) at 1:250 dilution, polyclonal rabbit anti-RI&#x003b2; (cat # SC-907, Santa Cruz Biotechnology, Inc.), anti-RII&#x003b1; (cat # 612243, BD Transduction laboratories) at 1:400 dilution or mouse monoclonal anti-RI&#x003b1; (Clone 4D7, [<xref ref-type="bibr" rid="B65">65</xref>]) at 1:300 dilution. Immunoreactive proteins were detected with HRP-conjugated secondary antibodies (ICN Diagnostics) and SuperSignal<sup>&#x000ae; </sup>West Pico Chemiluminiscent (Pierce).</p></sec><sec><title>Phosphotransferase assays</title><p>PKA-specific catalytic activity was determined as described previously [<xref ref-type="bibr" rid="B66">66</xref>]. Molar amounts of C subunit were determined assuming 600 pmol phosphate transferred per min per mg pure bovine C.</p></sec><sec><title>Luciferase assay</title><p>Briefly, 24 hours post transfection cells were harvested, lysed by sonication, and samples adjusted to equal protein concentrations (1 mg/mL). Lysates were added appropriate buffer containing 270 &#x003bc;M Coenzyme A (Boehringer), 530 &#x003bc;M ATP (Boehringer), 470 &#x003bc;M Luciferin (SynChem), and immediately placed in a Luminometer (TD20/20, Turner Designs). Luminosity was measured after 2 seconds delay at 560 nm for 15 seconds with 20.1% of intensity. Samples in the high end of luminosity were used to create a standard curve to ensure measurement in the linear range.</p></sec><sec><title>R-binding assay</title><p>The level of R-subunits was determined by specific [<sup>3</sup>H]-cAMP binding in homogenates from transfected 293T cells as previously described [<xref ref-type="bibr" rid="B15">15</xref>]. Molar amounts of R subunits were calculated assuming two cAMP binding sites per R subunit.</p></sec><sec><title>Indirect Immunofluorescence (IF)</title><p>IF of 293T cells were performed as previously described [<xref ref-type="bibr" rid="B67">67</xref>]. Antibodies against RI (Clone 4D7, [<xref ref-type="bibr" rid="B65">65</xref>]) and RII (cat # 612243, BD Transduction laboratories) were diluted (see figure legend). The anti-C antibodies were rabbit polyclonal anti-C&#x003b1; 1:100 (cat # sc 903, Santa Cruz Biotechnology, Santa Cruz, CA).</p></sec><sec><title>Statistics</title><p>Data are presented as means &#x000b1; s.e.m and were analyzed by unpaired two-tailed t test or by one-way analysis. A value of &#x0003c;0.05 was considered statistically significant. All statistics were calculated by the Graphpad prism 5.02 program.</p></sec></sec><sec><title>List of abbreviations</title><p>C: catalytic subunit; CREB: cAMP-responsive element binding protein; PKA: protein kinase A; R: regulatory subunit of PKA.</p></sec><sec><title>Authors' contributions</title><p>&#x000d8;S carried out most of the experiments, participated in the design of the study and in drafting the manuscript and preparing it for submission. ACVL participated in the experiments, provided technical assistance and contributed in criticizing the manuscript. AK performed indirect immunofluorescence experiments and contributed in criticizing the manuscript. SE participated in indirect immunofluorescence experiments and provided technical assistance. S&#x000d8; conceived the design of the study, helped in its coordination and contributed in criticizing the manuscript. BSS conceived the design of the study, helped in its coordination and wrote the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>This work was supported by the Research Council of Norway, the Norwegian Cancer Society, the Novo Nordisk foundation and the Throne Holst foundation.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Butcher</surname><given-names>RW</given-names></name><name><surname>Ho</surname><given-names>RJ</given-names></name><name><surname>Meng</surname><given-names>HC</given-names></name><name><surname>Sutherland</surname><given-names>EW</given-names></name><article-title>Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine</article-title><source>J Biol Chem</source><year>1965</year><volume>240</volume><fpage>4515</fpage><lpage>4523</lpage><pub-id pub-id-type="pmid">4378937</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>DA</given-names></name><name><surname>Perkins</surname><given-names>JP</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><article-title>An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle</article-title><source>J Biol Chem</source><year>1968</year><volume>243</volume><fpage>3763</fpage><lpage>3765</lpage><pub-id pub-id-type="pmid">4298072</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Doskeland</surname><given-names>SO</given-names></name><article-title>Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3'; 5'-cyclic monophosphate</article-title><source>Biochem Biophys Res Commun</source><year>1978</year><volume>83</volume><fpage>542</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(78)91024-0</pub-id><pub-id pub-id-type="pmid">212058</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Corbin</surname><given-names>JD</given-names></name><name><surname>Keely</surname><given-names>SL</given-names></name><name><surname>Park</surname><given-names>CR</given-names></name><article-title>The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues</article-title><source>J Biol Chem</source><year>1975</year><volume>250</volume><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">166986</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Reimann</surname><given-names>EM</given-names></name><name><surname>Brostrom</surname><given-names>CO</given-names></name><name><surname>Corbin</surname><given-names>JD</given-names></name><name><surname>King</surname><given-names>CA</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><article-title>Separation of regulatory and catalytic subunits of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase(s) of rabbit skeletal muscle</article-title><source>Biochem Biophys Res Commun</source><year>1971</year><volume>42</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(71)90086-6</pub-id><pub-id pub-id-type="pmid">4322813</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Maller</surname><given-names>JL</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><article-title>In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase</article-title><source>Proc Natl Acad Sci USA</source><year>1978</year><volume>75</volume><fpage>248</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1073/pnas.75.1.248</pub-id><pub-id pub-id-type="pmid">203933</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Montminy</surname><given-names>MR</given-names></name><name><surname>Bilezikjian</surname><given-names>LM</given-names></name><article-title>Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene</article-title><source>Nature</source><year>1987</year><volume>328</volume><fpage>175</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/328175a0</pub-id><pub-id pub-id-type="pmid">2885756</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Yamamoto</surname><given-names>KK</given-names></name><name><surname>Gonzalez</surname><given-names>GA</given-names></name><name><surname>Biggs</surname><given-names>WH</given-names></name><name><surname>Montminy</surname><given-names>MR</given-names></name><article-title>Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB</article-title><source>Nature</source><year>1988</year><volume>334</volume><fpage>494</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/334494a0</pub-id><pub-id pub-id-type="pmid">2900470</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Skalhegg</surname><given-names>BS</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><article-title>Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA</article-title><source>Front Biosci</source><year>2000</year><volume>5</volume><fpage>D678</fpage><lpage>D693</lpage><pub-id pub-id-type="doi">10.2741/Skalhegg</pub-id><pub-id pub-id-type="pmid">10922298</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Solberg</surname><given-names>R</given-names></name><name><surname>Sandberg</surname><given-names>M</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Torjesen</surname><given-names>PA</given-names></name><name><surname>Hansson</surname><given-names>V</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><article-title>The human gene for the regulatory subunit RI alpha of cyclic adenosine 3', 5'-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids</article-title><source>Endocrinology</source><year>1997</year><volume>138</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1210/en.138.1.169</pub-id><pub-id pub-id-type="pmid">8977401</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Barradeau</surname><given-names>S</given-names></name><name><surname>Imaizumi-Scherrer</surname><given-names>T</given-names></name><name><surname>Weiss</surname><given-names>MC</given-names></name><name><surname>Faust</surname><given-names>DM</given-names></name><article-title>Alternative 5'-exons of the mouse cAMP-dependent protein kinase subunit RIalpha gene are conserved and expressed in both a ubiquitous and tissue-restricted fashion</article-title><source>FEBS Lett</source><year>2000</year><volume>476</volume><fpage>272</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01653-7</pub-id><pub-id pub-id-type="pmid">10913627</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Dahle</surname><given-names>MK</given-names></name><name><surname>Knutsen</surname><given-names>HK</given-names></name><name><surname>Tasken</surname><given-names>KA</given-names></name><name><surname>Pilz</surname><given-names>R</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><article-title>Cyclic AMP regulates expression of the RI alpha subunit of cAMP-dependent protein kinase through an alternatively spliced 5' UTR</article-title><source>Eur J Biochem</source><year>2001</year><volume>268</volume><fpage>5920</fpage><lpage>5929</lpage><pub-id pub-id-type="doi">10.1046/j.0014-2956.2001.02542.x</pub-id><pub-id pub-id-type="pmid">11722580</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Johansson</surname><given-names>CC</given-names></name><name><surname>Dahle</surname><given-names>MK</given-names></name><name><surname>Blomqvist</surname><given-names>SR</given-names></name><name><surname>Gronning</surname><given-names>LM</given-names></name><name><surname>Aandahl</surname><given-names>EM</given-names></name><name><surname>Enerback</surname><given-names>S</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><article-title>A winged helix forkhead (FOXD2) tunes sensitivity to cAMP in T lymphocytes through regulation of cAMP-dependent protein kinase RIalpha</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>17573</fpage><lpage>17579</lpage><pub-id pub-id-type="doi">10.1074/jbc.M300311200</pub-id><pub-id pub-id-type="pmid">12621056</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Oyen</surname><given-names>O</given-names></name><name><surname>Myklebust</surname><given-names>F</given-names></name><name><surname>Scott</surname><given-names>JD</given-names></name><name><surname>Hansson</surname><given-names>V</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><article-title>Human testis cDNA for the regulatory subunit RII alpha of cAMP-dependent protein kinase encodes an alternate amino-terminal region</article-title><source>FEBS Lett</source><year>1989</year><volume>246</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(89)80253-4</pub-id><pub-id pub-id-type="pmid">2540040</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Kvissel</surname><given-names>AK</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Oistad</surname><given-names>P</given-names></name><name><surname>Rootwelt</surname><given-names>T</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Induction of Cbeta splice variants and formation of novel forms of protein kinase A type II holoenzymes during retinoic acid-induced differentiation of human NT2 cells</article-title><source>Cell Signal</source><year>2004</year><volume>16</volume><fpage>577</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2003.08.014</pub-id><pub-id pub-id-type="pmid">14751543</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Reinton</surname><given-names>N</given-names></name><name><surname>Frengen</surname><given-names>E</given-names></name><name><surname>Langeland</surname><given-names>BT</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Identification of novel splice variants of the human catalytic subunit Cbeta of cAMP-dependent protein kinase</article-title><source>Eur J Biochem</source><year>2001</year><volume>268</volume><fpage>5066</fpage><lpage>5073</lpage><pub-id pub-id-type="doi">10.1046/j.0014-2956.2001.02429.x</pub-id><pub-id pub-id-type="pmid">11589697</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Reinton</surname><given-names>N</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Haugen</surname><given-names>TB</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>A novel isoform of human cyclic 3',5'-adenosine monophosphate-dependent protein kinase, c alpha-s, localizes to sperm midpiece</article-title><source>Biol Reprod</source><year>2000</year><volume>63</volume><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1095/biolreprod63.2.607</pub-id><pub-id pub-id-type="pmid">10906071</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Showers</surname><given-names>MO</given-names></name><name><surname>Maurer</surname><given-names>RA</given-names></name><article-title>Cloning of cDNA for the catalytic subunit of cAMP-dependent protein kinase</article-title><source>Methods Enzymol</source><year>1988</year><volume>159</volume><fpage>311</fpage><lpage>318</lpage><comment>full_text</comment><pub-id pub-id-type="pmid">3412179</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Uhler</surname><given-names>MD</given-names></name><name><surname>Carmichael</surname><given-names>DF</given-names></name><name><surname>Lee</surname><given-names>DC</given-names></name><name><surname>Chrivia</surname><given-names>JC</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase</article-title><source>Proc Natl Acad Sci USA</source><year>1986</year><volume>83</volume><fpage>1300</fpage><lpage>1304</lpage><pub-id pub-id-type="doi">10.1073/pnas.83.5.1300</pub-id><pub-id pub-id-type="pmid">3456589</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Wiemann</surname><given-names>S</given-names></name><name><surname>Kinzel</surname><given-names>V</given-names></name><name><surname>Pyerin</surname><given-names>W</given-names></name><article-title>Isoform C beta 2, an unusual form of the bovine catalytic subunit of cAMP-dependent protein kinase</article-title><source>J Biol Chem</source><year>1991</year><volume>266</volume><fpage>5140</fpage><lpage>5146</lpage><pub-id pub-id-type="pmid">2002051</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Desseyn</surname><given-names>JL</given-names></name><name><surname>Burton</surname><given-names>KA</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>6433</fpage><lpage>6438</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.12.6433</pub-id><pub-id pub-id-type="pmid">10841548</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Guthrie</surname><given-names>CR</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>Two novel brain-specific splice variants of the murine Cbeta gene of cAMP-dependent protein kinase</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>29560</fpage><lpage>29565</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.47.29560</pub-id><pub-id pub-id-type="pmid">9368018</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Biemann</surname><given-names>K</given-names></name><name><surname>Shoji</surname><given-names>S</given-names></name><name><surname>Parmelee</surname><given-names>DC</given-names></name><name><surname>Titani</surname><given-names>K</given-names></name><article-title>n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle</article-title><source>Proc Natl Acad Sci USA</source><year>1982</year><volume>79</volume><fpage>6128</fpage><lpage>6131</lpage><pub-id pub-id-type="doi">10.1073/pnas.79.20.6128</pub-id><pub-id pub-id-type="pmid">6959104</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Jedrzejewski</surname><given-names>PT</given-names></name><name><surname>Girod</surname><given-names>A</given-names></name><name><surname>Tholey</surname><given-names>A</given-names></name><name><surname>Konig</surname><given-names>N</given-names></name><name><surname>Thullner</surname><given-names>S</given-names></name><name><surname>Kinzel</surname><given-names>V</given-names></name><name><surname>Bossemeyer</surname><given-names>D</given-names></name><article-title>A conserved deamidation site at Asn 2 in the catalytic subunit of mammalian cAMP-dependent protein kinase detected by capillary LC-MS and tandem mass spectrometry</article-title><source>Protein Sci</source><year>1998</year><volume>7</volume><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1002/pro.5560070227</pub-id><pub-id pub-id-type="pmid">9521123</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Herberg</surname><given-names>FW</given-names></name><name><surname>Bell</surname><given-names>SM</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli: multiple isozymes reflect different phosphorylation states</article-title><source>Protein Eng</source><year>1993</year><volume>6</volume><fpage>771</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1093/protein/6.7.771</pub-id><pub-id pub-id-type="pmid">8248101</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Toner-Webb</surname><given-names>J</given-names></name><name><surname>van Patten</surname><given-names>SM</given-names></name><name><surname>Walsh</surname><given-names>DA</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>25174</fpage><lpage>25180</lpage><pub-id pub-id-type="pmid">1460017</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Yonemoto</surname><given-names>W</given-names></name><name><surname>Garrod</surname><given-names>SM</given-names></name><name><surname>Bell</surname><given-names>SM</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>18626</fpage><lpage>18632</lpage><pub-id pub-id-type="pmid">8395513</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>San Agustin</surname><given-names>JT</given-names></name><name><surname>Leszyk</surname><given-names>JD</given-names></name><name><surname>Nuwaysir</surname><given-names>LM</given-names></name><name><surname>Witman</surname><given-names>GB</given-names></name><article-title>The catalytic subunit of the cAMP-dependent protein kinase of ovine sperm flagella has a unique amino-terminal sequence</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>24874</fpage><lpage>24883</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.38.24874</pub-id><pub-id pub-id-type="pmid">9733793</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Funderud</surname><given-names>A</given-names></name><name><surname>Henanger</surname><given-names>HH</given-names></name><name><surname>Hafte</surname><given-names>TT</given-names></name><name><surname>Amieux</surname><given-names>PS</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Identification, cloning and characterization of a novel 47 kDa murine PKA C subunit homologous to human and bovine Cbeta2</article-title><source>BMC Biochem</source><year>2006</year><volume>7</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/1471-2091-7-20</pub-id><pub-id pub-id-type="pmid">16889664</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Funderud</surname><given-names>A</given-names></name><name><surname>Hafte</surname><given-names>TT</given-names></name><name><surname>Eikvar</surname><given-names>S</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Identification and characterization of novel PKA holoenzymes in human T lymphocytes</article-title><source>FEBS J</source><year>2005</year><volume>272</volume><fpage>1559</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2005.04568.x</pub-id><pub-id pub-id-type="pmid">15794744</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Fossberg</surname><given-names>TM</given-names></name><name><surname>Doskeland</surname><given-names>SO</given-names></name><name><surname>Ueland</surname><given-names>PM</given-names></name><article-title>Protein kinases in human renal cell carcinoma and renal cortex. A comparison of isozyme distribution and of responsiveness to adenosine 3':5'-cyclic monophosphate</article-title><source>Arch Biochem Biophys</source><year>1978</year><volume>189</volume><fpage>272</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(78)90224-2</pub-id><pub-id pub-id-type="pmid">213022</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Goel</surname><given-names>S</given-names></name><name><surname>Desai</surname><given-names>K</given-names></name><name><surname>Bulgaru</surname><given-names>A</given-names></name><name><surname>Fields</surname><given-names>A</given-names></name><name><surname>Goldberg</surname><given-names>G</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Grindel</surname><given-names>M</given-names></name><name><surname>Mani</surname><given-names>S</given-names></name><article-title>A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumors</article-title><source>Clin Cancer Res</source><year>2003</year><volume>9</volume><fpage>4069</fpage><lpage>4076</lpage><pub-id pub-id-type="pmid">14519628</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Bradbury</surname><given-names>AW</given-names></name><name><surname>Carter</surname><given-names>DC</given-names></name><name><surname>Miller</surname><given-names>WR</given-names></name><name><surname>Cho-Chung</surname><given-names>YS</given-names></name><name><surname>Clair</surname><given-names>T</given-names></name><article-title>Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa</article-title><source>Br J Cancer</source><year>1994</year><volume>69</volume><fpage>738</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1038/bjc.1994.139</pub-id><pub-id pub-id-type="pmid">8142263</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>McDaid</surname><given-names>HM</given-names></name><name><surname>Cairns</surname><given-names>MT</given-names></name><name><surname>Atkinson</surname><given-names>RJ</given-names></name><name><surname>McAleer</surname><given-names>S</given-names></name><name><surname>Harkin</surname><given-names>DP</given-names></name><name><surname>Gilmore</surname><given-names>P</given-names></name><name><surname>Johnston</surname><given-names>PG</given-names></name><article-title>Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer</article-title><source>Br J Cancer</source><year>1999</year><volume>79</volume><fpage>933</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6690149</pub-id><pub-id pub-id-type="pmid">10070893</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Amieux</surname><given-names>PS</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>The essential role of RI alpha in the maintenance of regulated PKA activity</article-title><source>Ann N Y Acad Sci</source><year>2002</year><volume>968</volume><fpage>75</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04328.x</pub-id><pub-id pub-id-type="pmid">12119269</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Kirschner</surname><given-names>LS</given-names></name><name><surname>Kusewitt</surname><given-names>DF</given-names></name><name><surname>Matyakhina</surname><given-names>L</given-names></name><name><surname>Towns</surname><given-names>WH</given-names></name><name><surname>Carney</surname><given-names>JA</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name><name><surname>Stratakis</surname><given-names>CA</given-names></name><article-title>A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>4506</fpage><lpage>4514</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0580</pub-id><pub-id pub-id-type="pmid">15930266</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Kirschner</surname><given-names>LS</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>Jones</surname><given-names>GN</given-names></name><name><surname>Mahoney</surname><given-names>E</given-names></name><article-title>Mouse models of altered protein kinase A signaling</article-title><source>Endocr Relat Cancer</source><year>2009</year><volume>16</volume><fpage>773</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1677/ERC-09-0068</pub-id><pub-id pub-id-type="pmid">19470615</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Erlichman</surname><given-names>J</given-names></name><name><surname>Rosenfeld</surname><given-names>R</given-names></name><name><surname>Rosen</surname><given-names>OM</given-names></name><article-title>Phosphorylation of a cyclic adenosine 3':5'-monophosphate-dependent protein kinase from bovine cardiac muscle</article-title><source>J Biol Chem</source><year>1974</year><volume>249</volume><fpage>5000</fpage><lpage>5003</lpage><pub-id pub-id-type="pmid">4367815</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>SH</given-names></name><name><surname>von</surname><given-names>DS</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity</article-title><source>Science</source><year>2007</year><volume>318</volume><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1126/science.1146447</pub-id><pub-id pub-id-type="pmid">17932298</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Beene</surname><given-names>DL</given-names></name><name><surname>Scott</surname><given-names>JD</given-names></name><article-title>A-kinase anchoring proteins take shape</article-title><source>Curr Opin Cell Biol</source><year>2007</year><volume>19</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2007.02.011</pub-id><pub-id pub-id-type="pmid">17317140</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Tasken</surname><given-names>K</given-names></name><name><surname>Aandahl</surname><given-names>EM</given-names></name><article-title>Localized effects of cAMP mediated by distinct routes of protein kinase A</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><fpage>137</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1152/physrev.00021.2003</pub-id><pub-id pub-id-type="pmid">14715913</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Manni</surname><given-names>S</given-names></name><name><surname>Mauban</surname><given-names>JH</given-names></name><name><surname>Ward</surname><given-names>CW</given-names></name><name><surname>Bond</surname><given-names>M</given-names></name><article-title>Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>24145</fpage><lpage>24154</lpage><pub-id pub-id-type="doi">10.1074/jbc.M802278200</pub-id><pub-id pub-id-type="pmid">18550536</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Witt</surname><given-names>JJ</given-names></name><name><surname>Roskoski</surname><given-names>R</given-names><suffix>Jr</suffix></name><article-title>Rapid protein kinase assay using phosphocellulose-paper absorption</article-title><source>Anal Biochem</source><year>1975</year><volume>66</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(75)90743-5</pub-id><pub-id pub-id-type="pmid">1147218</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Graves</surname><given-names>DJ</given-names></name><name><surname>Benjamini</surname><given-names>E</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><article-title>Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase</article-title><source>J Biol Chem</source><year>1977</year><volume>252</volume><fpage>4888</fpage><lpage>4894</lpage><pub-id pub-id-type="pmid">194899</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Mellon</surname><given-names>PL</given-names></name><name><surname>Clegg</surname><given-names>CH</given-names></name><name><surname>Correll</surname><given-names>LA</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>Regulation of transcription by cyclic AMP-dependent protein kinase</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>4887</fpage><lpage>4891</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.13.4887</pub-id><pub-id pub-id-type="pmid">2544878</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Alhanaty</surname><given-names>E</given-names></name><name><surname>Shaltiel</surname><given-names>S</given-names></name><article-title>Limited proteolysis of the catalytic subunit of cAMP-dependent protein kinase--a membranal regulatory device?</article-title><source>Biochem Biophys Res Commun</source><year>1979</year><volume>89</volume><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(79)90633-8</pub-id><pub-id pub-id-type="pmid">226083</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Skalhegg</surname><given-names>BS</given-names></name><name><surname>Johansen</surname><given-names>AK</given-names></name><name><surname>Levy</surname><given-names>FO</given-names></name><name><surname>Andersson</surname><given-names>KB</given-names></name><name><surname>Aandahl</surname><given-names>EM</given-names></name><name><surname>Blomhoff</surname><given-names>HK</given-names></name><name><surname>Hansson</surname><given-names>V</given-names></name><name><surname>Tasken</surname><given-names>K</given-names></name><article-title>Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines</article-title><source>J Cell Physiol</source><year>1998</year><volume>177</volume><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199810)177:1&#x0003c;85::AID-JCP9&#x0003e;3.0.CO;2-A</pub-id><pub-id pub-id-type="pmid">9731748</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Harootunian</surname><given-names>AT</given-names></name><name><surname>Adams</surname><given-names>SR</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Meinkoth</surname><given-names>JL</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name><article-title>Movement of the free catalytic subunit of cAMP-dependent protein kinase into and out of the nucleus can be explained by diffusion</article-title><source>Mol Biol Cell</source><year>1993</year><volume>4</volume><fpage>993</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">8298196</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Genieser</surname><given-names>HG</given-names></name><name><surname>Winkler</surname><given-names>E</given-names></name><name><surname>Butt</surname><given-names>E</given-names></name><name><surname>Zorn</surname><given-names>M</given-names></name><name><surname>Schulz</surname><given-names>S</given-names></name><name><surname>Iwitzki</surname><given-names>F</given-names></name><name><surname>Stormann</surname><given-names>R</given-names></name><name><surname>Jastorff</surname><given-names>B</given-names></name><name><surname>Doskeland</surname><given-names>SO</given-names></name><name><surname>Ogreid</surname><given-names>D</given-names></name><etal/><article-title>Derivatives of 1-beta-D-ribofuranosylbenzimidazole 3',5'-phosphate that mimic the actions of adenosine 3',5'-phosphate (cAMP) and guanosine 3',5'-phosphate (cGMP)</article-title><source>Carbohydr Res</source><year>1992</year><volume>234</volume><fpage>217</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/0008-6215(92)85050-A</pub-id><pub-id pub-id-type="pmid">1334800</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Kvissel</surname><given-names>AK</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Eikvar</surname><given-names>S</given-names></name><name><surname>Brede</surname><given-names>G</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Collas</surname><given-names>P</given-names></name><name><surname>Akusjarvi</surname><given-names>G</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing</article-title><source>Exp Cell Res</source><year>2007</year><volume>313</volume><fpage>2795</fpage><lpage>2809</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2007.05.014</pub-id><pub-id pub-id-type="pmid">17594903</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Kopperud</surname><given-names>R</given-names></name><name><surname>Christensen</surname><given-names>AE</given-names></name><name><surname>Kjarland</surname><given-names>E</given-names></name><name><surname>Viste</surname><given-names>K</given-names></name><name><surname>Kleivdal</surname><given-names>H</given-names></name><name><surname>Doskeland</surname><given-names>SO</given-names></name><article-title>Formation of inactive cAMP-saturated holoenzyme of cAMP-dependent protein kinase under physiological conditions</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>13443</fpage><lpage>13448</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109869200</pub-id><pub-id pub-id-type="pmid">11834733</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Viste</surname><given-names>K</given-names></name><name><surname>Kopperud</surname><given-names>RK</given-names></name><name><surname>Christensen</surname><given-names>AE</given-names></name><name><surname>Doskeland</surname><given-names>SO</given-names></name><article-title>Substrate enhances the sensitivity of type I protein kinase a to cAMP</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>13279</fpage><lpage>13284</lpage><pub-id pub-id-type="doi">10.1074/jbc.M413065200</pub-id><pub-id pub-id-type="pmid">15691833</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Di</surname><given-names>BG</given-names></name><name><surname>Zoccarato</surname><given-names>A</given-names></name><name><surname>Lissandron</surname><given-names>V</given-names></name><name><surname>Terrin</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Baillie</surname><given-names>GS</given-names></name><name><surname>Zaccolo</surname><given-names>M</given-names></name><article-title>Protein kinase A type I and type II define distinct intracellular signaling compartments</article-title><source>Circ Res</source><year>2008</year><volume>103</volume><fpage>836</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.174813</pub-id><pub-id pub-id-type="pmid">18757829</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Boundy</surname><given-names>VA</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name><article-title>Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells</article-title><source>J Pharmacol Exp Ther</source><year>1998</year><volume>286</volume><fpage>1058</fpage><lpage>1065</lpage><pub-id pub-id-type="pmid">9694969</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Cadd</surname><given-names>GG</given-names></name><name><surname>Uhler</surname><given-names>MD</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name><article-title>Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides</article-title><source>J Biol Chem</source><year>1990</year><volume>265</volume><fpage>19502</fpage><lpage>19506</lpage><pub-id pub-id-type="pmid">2174040</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Herberg</surname><given-names>FW</given-names></name><name><surname>Zimmermann</surname><given-names>B</given-names></name><name><surname>McGlone</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>Importance of the A-helix of the catalytic subunit of cAMP-dependent protein kinase for stability and for orienting subdomains at the cleft interface</article-title><source>Protein Sci</source><year>1997</year><volume>6</volume><fpage>569</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1002/pro.5560060306</pub-id><pub-id pub-id-type="pmid">9070439</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Sastri</surname><given-names>M</given-names></name><name><surname>Barraclough</surname><given-names>DM</given-names></name><name><surname>Carmichael</surname><given-names>PT</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><article-title>A-kinase-interacting protein localizes protein kinase A in the nucleus</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408608102</pub-id><pub-id pub-id-type="pmid">15630084</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Bossemeyer</surname><given-names>D</given-names></name><name><surname>Engh</surname><given-names>RA</given-names></name><name><surname>Kinzel</surname><given-names>V</given-names></name><name><surname>Ponstingl</surname><given-names>H</given-names></name><name><surname>Huber</surname><given-names>R</given-names></name><article-title>Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24)</article-title><source>EMBO J</source><year>1993</year><volume>12</volume><fpage>849</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">8384554</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Knighton</surname><given-names>DR</given-names></name><name><surname>Xuong</surname><given-names>NH</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Sowadski</surname><given-names>JM</given-names></name><name><surname>Ten Eyck</surname><given-names>LF</given-names></name><article-title>Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations</article-title><source>Protein Sci</source><year>1993</year><volume>2</volume><fpage>1559</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1002/pro.5560021003</pub-id><pub-id pub-id-type="pmid">8251932</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Gangal</surname><given-names>M</given-names></name><name><surname>Clifford</surname><given-names>T</given-names></name><name><surname>Deich</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Johnson</surname><given-names>DA</given-names></name><article-title>Mobilization of the A-kinase N-myristate through an isoform-specific intermolecular switch</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>12394</fpage><lpage>12399</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.22.12394</pub-id><pub-id pub-id-type="pmid">10535933</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Pepperkok</surname><given-names>R</given-names></name><name><surname>Hotz-Wagenblatt</surname><given-names>A</given-names></name><name><surname>Konig</surname><given-names>N</given-names></name><name><surname>Girod</surname><given-names>A</given-names></name><name><surname>Bossemeyer</surname><given-names>D</given-names></name><name><surname>Kinzel</surname><given-names>V</given-names></name><article-title>Intracellular distribution of mammalian protein kinase A catalytic subunit altered by conserved Asn2 deamidation</article-title><source>J Cell Biol</source><year>2000</year><volume>148</volume><fpage>715</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1083/jcb.148.4.715</pub-id><pub-id pub-id-type="pmid">10684253</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Hanakam</surname><given-names>F</given-names></name><name><surname>Gerisch</surname><given-names>G</given-names></name><name><surname>Lotz</surname><given-names>S</given-names></name><name><surname>Alt</surname><given-names>T</given-names></name><name><surname>Seelig</surname><given-names>A</given-names></name><article-title>Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>11036</fpage><lpage>11044</lpage><pub-id pub-id-type="doi">10.1021/bi960789j</pub-id><pub-id pub-id-type="pmid">8780505</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Hanakam</surname><given-names>F</given-names></name><name><surname>Albrecht</surname><given-names>R</given-names></name><name><surname>Eckerskorn</surname><given-names>C</given-names></name><name><surname>Matzner</surname><given-names>M</given-names></name><name><surname>Gerisch</surname><given-names>G</given-names></name><article-title>Myristoylated and non-myristoylated forms of the pH sensor protein hisactophilin II: intracellular shuttling to plasma membrane and nucleus monitored in real time by a fusion with green fluorescent protein</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>2935</fpage><lpage>2943</lpage><pub-id pub-id-type="pmid">8670794</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>McLaughlin</surname><given-names>S</given-names></name><name><surname>Aderem</surname><given-names>A</given-names></name><article-title>The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions</article-title><source>Trends Biochem Sci</source><year>1995</year><volume>20</volume><fpage>272</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(00)89042-8</pub-id><pub-id pub-id-type="pmid">7667880</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Skalhegg</surname><given-names>BS</given-names></name><name><surname>Landmark</surname><given-names>BF</given-names></name><name><surname>Doskeland</surname><given-names>SO</given-names></name><name><surname>Hansson</surname><given-names>V</given-names></name><name><surname>Lea</surname><given-names>T</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><article-title>Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3',5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>15707</fpage><lpage>15714</lpage><pub-id pub-id-type="pmid">1379235</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Larsen</surname><given-names>ACV</given-names></name><name><surname>Kvissel</surname><given-names>AK</given-names></name><name><surname>Hafte</surname><given-names>TT</given-names></name><name><surname>Avellan</surname><given-names>CIA</given-names></name><name><surname>Eikvar</surname><given-names>S</given-names></name><name><surname>Rootwelt</surname><given-names>T</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Inactive forms of the catalytic subunit of protein kinase A are expressed in the brain of higher primates</article-title><source>Febs Journal</source><year>2008</year><volume>275</volume><fpage>250</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2007.06195.x</pub-id><pub-id pub-id-type="pmid">18070107</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Kvissel</surname><given-names>AK</given-names></name><name><surname>Orstavik</surname><given-names>S</given-names></name><name><surname>Eikvar</surname><given-names>S</given-names></name><name><surname>Brede</surname><given-names>G</given-names></name><name><surname>Jahnsen</surname><given-names>T</given-names></name><name><surname>Collas</surname><given-names>P</given-names></name><name><surname>Akusjarvi</surname><given-names>G</given-names></name><name><surname>Skalhegg</surname><given-names>BS</given-names></name><article-title>Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing</article-title><source>Exp Cell Res</source><year>2007</year><volume>313</volume><fpage>2795</fpage><lpage>2809</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2007.05.014</pub-id><pub-id pub-id-type="pmid">17594903</pub-id></mixed-citation></ref></ref-list></back></article>